On July 16, Cigna Group fell 4.29% in regular trading, trading at 285.11 USD/share, with turnover of $381 million, extending its decline for a third consecutive trading day.

On the news front, the healthcare sector has been under collective selling pressure since July 15, with managed care peers broadly declining. Molina Healthcare fell 6.5%, Centene dropped 3.8%, UnitedHealth declined 1.9%, and Humana lost 1.6%, with no signs of sector-wide selling abating. Cigna's daily losses have widened progressively amid this industry-wide downturn.

The company's next earnings report is expected on July 30 before market open, with consensus EPS estimated at $7.58. Previously, Bernstein raised its price target to $381 maintaining an outperform rating, while the company posted Q1 adjusted EPS of $7.79, beating estimates by 2.4%, and raised full-year guidance to at least $30.35 per share. However, short-term systematic sector selling continues to dominate price action.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)